3Trop6 CG, Kaern J, Davidson B. Borderline ovarian tumours [J]. Best Pract Res Clin Obstet Gynaecol, 2012,26 : 325-336.
4Bendifallah S, Ballester M, Uzan C, et al. Nomogram to predict recurrence in patients with early-and advanced-stage mucinous and serous borderline ovarian tumors[J]. Am J Obstet Gynecol, 2014,211 : 637. el-6.
6Alvarez RM,Vazquez-Vicente D. Fertility sparing treatment in borderline ovarian tumours[J]. Ecancer medical science, 2015,9:507.
7Uzan C,Muller E, Kane A, et al. Fertility sparing treatment o{ recurrent stage I serous borderline ovarian tumours[J]. Hum Reprod,2013,28 : 3222-3226.
8Song T, Choi CH, Park HS, et al. Fertility-sparing surgery forborderline ovarian tumors: oncologic sa{ety and reproductive outcomes[J]. Int J Gynecol Cancer,2011,21:640-646.
9Vasconeelos I,de Sousa Mendes M. Conservative surgery in ovarian borderline tumours:a meta-analysis with emphasis on recurrence risk[J]. Eur J Cancer, 2015,51 : 620-631.
10Frega A, Coluccia AC, Di Martino G, et al. Borderline ovarian tumors,fertility-sparing surgery and pregnancy outcome[J]. Eur Rev Med Pharmacol Sci, 2014,18 = 281-284.
